Literature DB >> 19448915

Survival of breast cancer women in the state of Rio de Janeiro, Southeastern Brazil.

Claudia Brito1, Margareth Crisóstomo Portela, Mauricio Teixeira Leite de Vasconcellos.   

Abstract

OBJECTIVE: To assess the association between breast cancer survival and infrastructure and practices of cancer care units.
METHODS: Retrospective longitudinal study based on data from the Brazilian information system of authorizations for highly complex cancer procedures covered by the National Health System and a sample of 310 medical records of prevalent breast cancer cases attended at 15 inpatient and outpatient cancer care units providing chemotherapy between 1999 and 2002 in the state of Rio de Janeiro, Southeastern Brazil. Independent variables were infrastructure of cancer units, interventions, and sociodemographic and clinical characteristics of women. Kaplan-Meier method and Cox proportional hazards model (pseudolikelihood) were used for data analysis.
RESULTS: Kaplan-Meier analyses pointed out significant associations between survival and time between diagnosis and treatment start, surgery, hormone therapy, type of adjuvant hormone therapy, therapy combinations, type of care unit and health insurance, unit size and category. Estimates obtained from the Cox model showed positive associations between hazard of death and time between diagnosis and treatment, unit size and type combined to use of health insurance, and negative associations between survival and surgery and type of hormone therapy.
CONCLUSIONS: The study findings show an association between breast cancer survival and health care provided by affiliated services with practical implications for policy making for cancer control in Brazil.

Entities:  

Mesh:

Year:  2009        PMID: 19448915     DOI: 10.1590/s0034-89102009000300012

Source DB:  PubMed          Journal:  Rev Saude Publica        ISSN: 0034-8910            Impact factor:   2.106


  7 in total

Review 1.  A review of breast cancer care and outcomes in Latin America.

Authors:  Nahila Justo; Nils Wilking; Bengt Jönsson; Silvana Luciani; Eduardo Cazap
Journal:  Oncologist       Date:  2013-02-26

2.  Effect of Agaricus sylvaticus supplementation on nutritional status and adverse events of chemotherapy of breast cancer: a randomized, placebo-controlled, double-blind clinical trial.

Authors:  Fabiana Valadares; Maria Rita Carvalho Garbi Novaes; Roberto Cañete
Journal:  Indian J Pharmacol       Date:  2013 May-Jun       Impact factor: 1.200

3.  Breast cancer mortality and associated factors in São Paulo State, Brazil: an ecological analysis.

Authors:  Carmen Simone Grilo Diniz; Alessandra Cristina Guedes Pellini; Adeylson Guimarães Ribeiro; Marcello Vannucci Tedardi; Marina Jorge de Miranda; Michelle Mosna Touso; Oswaldo Santos Baquero; Patrícia Carlos Dos Santos; Francisco Chiaravalloti-Neto
Journal:  BMJ Open       Date:  2017-08-23       Impact factor: 2.692

4.  Prevalence of dermatological complaints in patients undergoing treatment for breast cancer.

Authors:  Tamara Hoffmann; Mariane Corrêa-Fissmer; Camila Soares Duarte; Rayane Felippe Nazário; Ana Beatriz Sanches Barranco; Karen Waleska Knipoff de Oliveira
Journal:  An Bras Dermatol       Date:  2018-06       Impact factor: 1.896

5.  Survival of patients with operable breast cancer (Stages I-III) at a Brazilian public hospital--a closer look into cause-specific mortality.

Authors:  Débora Balabram; Cassio M Turra; Helenice Gobbi
Journal:  BMC Cancer       Date:  2013-09-24       Impact factor: 4.430

6.  Adherence to hormone therapy among women with breast cancer.

Authors:  Claudia Brito; Margareth Crisóstomo Portela; Mauricio Teixeira Leite de Vasconcellos
Journal:  BMC Cancer       Date:  2014-06-03       Impact factor: 4.430

7.  Analysis of breast cancer survival in a northeastern Brazilian state based on prognostic factors: A retrospective cohort study.

Authors:  Adriane Dórea Marques; Alex Rodrigues Moura; Evânia Curvelo Hora; Érika de Abreu Costa Brito; Leonardo Souto Oliviera; Ionara Rodrigues Feitosa; Flavia Fernandes Freitas; Marcela Sampaio Lima; Íkaro Daniel de Carvalho Barreto; Marceli Oliveira Santos; Angela Maria da Silva; Carlos Anselmo Lima
Journal:  PLoS One       Date:  2022-02-03       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.